Late De Novo Minimal Change Disease in a Renal Allograft

被引:0
|
作者
Madhan, Krishan K. [1 ]
Temple-Camp, Cynric R. E. [2 ]
机构
[1] Taranaki Dist Hlth Board, Renal Unit, Private Bag 2016, New Plymouth 4321, New Zealand
[2] Medlab Cent, Anat Pathol, Palmerston North, New Zealand
关键词
Kidney Allograft; Transplantation; Nephrotic Syndrome; De novo Minimal change Disease;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Among the causes of the nephrotic syndrome in renal allografts, minimal change disease is a rarity with only few cases described in the medical literature. Most cases described have occurred early in the post-transplant course. There is no established treatment for the condition but prognosis is favorable. We describe a case of minimal change disease that developed 8 years after a successful transplantation of a renal allograft in a middle-aged woman. The nephrotic syndrome was accompanied by deterioration of allograft function. Treatment with mycophenolate mofetil was successful in inducing remission and stabilizing allograft function.
引用
收藏
页码:266 / 269
页数:4
相关论文
共 50 条
  • [31] Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies
    Boratynska, M.
    Wattorek, E.
    Smolska, D.
    Patrzalek, D.
    Klinger, M.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (09) : 2736 - 2739
  • [32] The Prevalence of Immunologic Injury in Renal Allograft Recipients with De Novo Proteinuria
    Sun, Qiquan
    Jiang, Song
    Li, Xue
    Huang, Xianghua
    Xie, Kenan
    Cheng, Dongrui
    Chen, Jinsong
    Ji, Shuming
    Wen, Jiqiu
    Zhang, Mingchao
    Zeng, Caihong
    Liu, Zhihong
    PLOS ONE, 2012, 7 (05):
  • [33] De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppression
    Rachelle Asciak
    Jesmar Buttigieg
    Louis Buhagiar
    CEN Case Reports, 2016, 5 (1) : 99 - 102
  • [34] DE NOVO FIBRILLARY GLOMERULONEPHRITIS IN A RENAL ALLOGRAFT OF A PATIENT WITH HEPATITIS C
    Santos, Jolina
    Polsani, Srujana
    Jim, Belinda
    Ansari, Naheed
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : A85 - A85
  • [35] DE-NOVO DIABETIC GLOMERULOSCLEROSIS IN A RENAL-ALLOGRAFT RECIPIENT
    SHARMA, UK
    JHA, V
    GUPTA, KL
    JOSHI, K
    SAKHUJA, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (04) : 597 - 599
  • [36] De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppression
    Asciak, Rachelle
    Buttigieg, Jesmar
    Buhagiar, Louis
    CEN CASE REPORTS, 2016, 5 (01): : 99 - 102
  • [37] Current trends in the management of de novo allograft renal tumour after renal transplantation
    Chua, D.
    Rhee, H.
    Paterdis, J.
    Preston, J.
    Lawson, M.
    BJU INTERNATIONAL, 2018, 121 : 76 - 77
  • [38] Recurrent and de novo renal diseases after renal transplantation in the cyclosporine era: Report from the renal allograft recurrent disease registry (RARDR).
    Hariharan, S
    Peddi, VR
    First, MR
    Savin, VJ
    Roza, AM
    Johnson, C
    Adams, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3319 - A3319
  • [39] De-Novo Focal Crescentic IgA Nephropathy in a Renal Allograft Recipient
    Ramasamy, Ashok
    Rangaswamy, Dharshan
    Vankalakunti, Mahesha
    Attur, Ravindra Prabhu
    Nagaraju, Shankar Prasad
    Rao, Indu
    INDIAN JOURNAL OF NEPHROLOGY, 2019, 29 (06) : 432 - +
  • [40] DE NOVO THROMBOTIC MICROANGIOPATHY IN RENAL ALLOGRAFT RECIPIENTS: ROLE OF MTOR INHIBITORS
    Nava, Fabio
    Mori, Giacomo
    Ciaravello, Antonio
    Magnoni, Giacomo
    Facchini, Francesca
    Leonelli, Marco
    Cappelli, Gianni
    Bonucchi, Decenzio
    TRANSPLANT INTERNATIONAL, 2013, 26 : 258 - 258